Houston, TX, United States of America

Natalie Blok


Average Co-Inventor Count = 4.2

ph-index = 6

Forward Citations = 93(Granted Patents)


Company Filing History:


Years Active: 1998-2004

Loading Chart...
8 patents (USPTO):

Title: The Innovative Contributions of Natalie Blok

Introduction

Natalie Blok is a prominent inventor based in Houston, Texas, known for her significant contributions to the field of pharmaceuticals. With a total of eight patents to her name, she has made remarkable advancements in the modulation of endothelin activity, which is crucial for treating various medical conditions.

Latest Patents

Her latest patents include innovative sulfonamides and their derivatives that modulate the activity of endothelin. These patents detail formulations of pharmaceutically acceptable derivatives and methods for altering the activity of the endothelin family of peptides. Notably, her work encompasses N-(isoxazolyl)thienylsulfonamides, N-(isoxazolyl)furylsulfonamides, N-(isoxazolyl)pyrrolylsulfonamides, and N-(isoxazolyl)phenylsulfonamides. These sulfonamides are designed to inhibit the binding of endothelin peptides to their receptors, providing methods for treating endothelin-mediated disorders.

Career Highlights

Throughout her career, Natalie has worked with notable companies such as Texas Biotechnology Corporation and Encysive Pharmaceuticals, Inc. Her expertise in pharmaceutical sciences has led to the development of effective treatments for endothelin-related diseases.

Collaborations

Natalie has collaborated with esteemed colleagues, including Chengde Wu and Timothy P. Kogan, to further her research and innovations in the field.

Conclusion

Natalie Blok's contributions to pharmaceutical innovation, particularly in the area of endothelin modulation, highlight her role as a leading inventor. Her work continues to impact the medical field positively, paving the way for new treatments and therapies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…